Form 4: ZimVie Director Kuntz Accrues Deferred Share Units

ZimVie Inc. Director Richard Kuntz accrued 662.309 deferred share units under the company's non-employee director compensation plan.

Summary

• Richard Kuntz, a Director of ZimVie Inc. (ZIMV), acquired 662.309 deferred share units.
• The transaction date for this acquisition was September 30, 2025.
• These deferred share units were accrued under the ZimVie Inc. Deferred Compensation Plan for Non-Employee Directors.
• Each deferred share unit has a conversion or exercise price of $18.93, converting on a 1-for-1 basis to Common Stock.
• The units are to be settled in cash after Mr. Kuntz ceases his service as a Director.
• Following this transaction, Mr. Kuntz beneficially owns a total of 13,072.965 deferred share units.

Sentiment

Score: 6

Explanation: Slightly positive, as it indicates a director's continued participation in the company's long-term incentive plan, aligning their interests with the company's performance, albeit through a cash-settled mechanism.

Positives

• The accrual of deferred share units indicates continued alignment of a director's interests with the long-term performance of the company.

Negatives

• The deferred share units are settled in cash upon cessation of service, rather than directly in equity, which may limit direct shareholder alignment compared to outright stock ownership.

Future Outlook

The deferred share units are scheduled to be settled in cash after Richard Kuntz ceases his service as a Director of ZimVie Inc.

Industry Context

Director deferred compensation plans are a common practice in publicly traded companies, designed to align the interests of non-employee directors with long-term shareholder value, often with settlement provisions tied to the end of service.

Comparison to Industry Standards

• The structure of accruing deferred share units for non-employee directors, with cash settlement upon cessation of service, is a standard practice in corporate governance and compensation across various industries, including the medical technology sector where ZimVie operates. Companies like Stryker Corporation or Zimmer Biomet Holdings, while not directly comparable in specific unit values, often utilize similar mechanisms to compensate their non-executive board members and foster long-term commitment.

Corporate Governance

Related Party Transactions

• Accrual of 662.309 deferred share units to Director Richard Kuntz under the company's Deferred Compensation Plan for Non-Employee Directors, valued at approximately $12,537.99.

Stakeholder Impact

• Shareholders: Indicates continued alignment of a director's interests with the company's long-term performance, which can be viewed positively.
• Employees: No direct impact mentioned.

Next Steps

• Settlement of the deferred share units in cash upon Richard Kuntz's cessation of service as a Director.

Key Dates

Recommendation

This Form 4 reports a routine accrual of deferred compensation for a non-employee director. It does not indicate any significant change in the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. The transaction is a standard part of director remuneration and is unlikely to have a material impact on the stock price or company fundamentals.

Keywords

ZimVie Inc., ZIMV, Richard Kuntz, Director, Deferred Share Units, Insider Transaction, SEC Form 4, Compensation Plan, Corporate Governance